EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pathogenesis of Chronic Arthritis Due to Chikungunya Virus and Advances in Vaccine Development

Meng Ma, Leyi Li, Hao Sun, Xiaochao Zhang

Viruses · 01.04.2026 · 18 (4) · 428

DOI: 10.3390/v18040428 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 01.04.2026. Verfasst von Meng Ma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Provincial Key Laboratory of Pharmacology for Natural Products, School of Pharmaceutical Sciences, Kunming Medical University, 1168 Yuhua Road…. Hauptthemen laut MEDLINE: Chikungunya virus, Vaccine Development, Chikungunya Fever, Viral Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yunnan Provincial Academician and Science & Technology Leading Talent Program, Yunnan Training Programme for the Advanced Talents of Health and Medical Technology, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chikungunya virus (CHIKungunya Virus, CHIKV) is a mosquito-borne plus-stranded RNA virus. Adaptive mutations such as A226V in the E1 envelope protein of CHIKV significantly enhance the transmission efficiency of the virus in Aedes albostriae, leading to multiple rounds of epidemics around the world including the large-scale outbreak in Guangdong Province in 2025. After a viral infection, a significant proportion of patients will progress from acute arthralgia to chronic arthritis that persists. The pathogenesis of the disease involves the persistence of the virus in joint tissues, the persistent inflammatory response with IL-1β, IL-6 and IL-17 as the core mediated by macrophages, possible autoimmune cross-reactions, and individual genetic susceptibility. At present, there is no specific antiviral drug, but important progress has been made in vaccine development against the virus. Vaccines based on live attenuated virus (VLA1553) and virus-like particle (VLP) platforms have been approved for the market and provide a tool to prevent and control this important public health threat. This review synthesizes current knowledge on CHIKV-induced chronic arthritis pathogenesis and recent vaccine advances, providing a framework for understanding disease mechanisms and guiding future prevention strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chikungunya virusVaccine DevelopmentChikungunya FeverViral VaccinesArthritisHumansAnimalsChronic DiseaseVaccines, Attenuated

Stichwörter der Autor:innen

chikungunyachronic arthritisepidemiologyimmunopathogenesispathogenesisvaccine

Substanzen

Viral VaccinesVaccines, Attenuated

Autor:innen und Institutionen

  • Yunnan Provincial Key Laboratory of Pharmacology for Natural Products, School of Pharmaceutical Sciences, Kunming Medical University, 1168 Yuhua Road, Kunming 650500, China.
  • Medical School, Kunming University of Science and Technology, 727 Jingming South Road, Kunming 650500, China.
  • Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, 935 Jiaoling Road, Kunming 650118, China.

Förderung

  • Yunnan Provincial Academician and Science & Technology Leading Talent Program
  • Yunnan Training Programme for the Advanced Talents of Health and Medical Technology
  • National Key Research and Development Program of China

Zitieren

APA

Ma, M., Li, L., Sun, H., & Zhang, X. (2026). Pathogenesis of Chronic Arthritis Due to Chikungunya Virus and Advances in Vaccine Development. Viruses, 18(4), 428. https://doi.org/10.3390/v18040428

Vancouver

Ma M, Li L, Sun H, Zhang X. Pathogenesis of Chronic Arthritis Due to Chikungunya Virus and Advances in Vaccine Development. Viruses. 2026;18(4):428. doi:10.3390/v18040428

BibTeX
@article{Ma2026,
  author = {Ma, Meng and Li, Leyi and Sun, Hao and Zhang, Xiaochao},
  title = {Pathogenesis of Chronic Arthritis Due to Chikungunya Virus and Advances in Vaccine Development},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {428},
  doi = {10.3390/v18040428}
}
Kostenlos starten →